A Study of Absorption, Metabolism, Excretion, and Absolute Bioavailability of Carbon-14-Labelled [14C] Selpercatinib (LY3527723) in Healthy Male Participants
Clinical trial NCT05630287 · COMPLETED
Trial details
- NCT number
- NCT05630287
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2018-09-24
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.